Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Abbvie gets USFDA approval for updated indication statement for Rinvoq for Inflammatory Bowel Disease

AbbVie concludes acquisition of ImmunoGen

Written By Ruchika Sharma14 Feb 2024 4:36 PM IST

North Chicago, Ill.: AbbVie has announced that it has completed its acquisition of ImmunoGen. With the completion of the acquisition,...

Quadria Capital-Led Consortium Eyes Majority Stake in Samarth Lifesciences at Rs 4,500 Cr Valuation

Eris buys 51 percent stake in Swiss Parenterals for Rs 637.5 crore

Written By Ruchika Sharma14 Feb 2024 3:33 PM IST

New Delhi: Eris Lifesciences has said it has acquired a 51 per cent stake in Swiss Parenterals for Rs 637.5 crore.Ahmedabad-based Swiss Parenterals is...

Natco Pharma gets 7 USFDA observations for Kothur Pharma Division

USFDA successfully concludes inspection at Unichem Labs Ghaziabad facility

Written By Ruchika Sharma14 Feb 2024 12:15 PM IST

Mumbai: Unichem Labs has announced that the United States Food and Drug Administration (USFDA) has successfully concluded inspection without any...

Lupin and TB Alliance Join Forces to Advance Telacebec

Lupin unveils Bromfenac Ophthalmic Solution, 0.075% in US

Written By Ruchika Sharma14 Feb 2024 11:30 AM IST

Mumbai: Global pharma major Lupin Limited has announced the launch of Bromfenac Ophthalmic Solution, 0.075%, after having received an approval...

Pfizer Secures Vyndamax Patent Till 2031

Pfizer, UT Southwestern collaborate to develop improved RNA Delivery Technologies

Written By Ruchika Sharma13 Feb 2024 4:30 PM IST

Dallas: UT Southwestern Medical Center is partnering with Pfizer Inc. to develop RNA-enhanced delivery technologies for genetic medicine...

Aurobindo Pharma arm Unit IV gets 5 USFDA observations

Dr Reddy's Labs gets USFDA VAI classification for Hyderabad RnD centre

Written By Ruchika Sharma13 Feb 2024 3:00 PM IST

Hyderabad: Dr Reddy's Laboratories has said the US health regulator has granted Voluntary Action Indicated (VAI) classification to its...

CDSCO Panel Flags Ethnic Variability, Seeks More Data from Takeda for Fruquintinib Hard Capsule Approval

Takeda Eohilia gets USFDA nod for people aged 11 years and older with eosinophilic esophagitis

Written By Ruchika Sharma13 Feb 2024 1:30 PM IST

Osaka: Takeda has announced that the U.S. Food and Drug Administration (FDA) has approved EOHILIA (budesonide oral suspension), the first and...

JnJ completes acquisition of Halda Therapeutics, its novel platform for cancer treatment

Gilead Sciences to acquire CymaBay Therapeutics for USD 4.3 billion

Written By Ruchika Sharma13 Feb 2024 12:30 PM IST

Foster City: Gilead Sciences, Inc. and CymaBay Therapeutics, Inc. have announced a definitive agreement under which Gilead will acquire CymaBay...

USFDA Approves Corcept Therapeutics Ovarian Cancer Drug Lifyorli

Aurobindo Pharma bags USFDA okay for Duchenne muscular dystrophy drug Deflazacort

Written By Ruchika Sharma13 Feb 2024 11:59 AM IST

Hyderabad: Aurobindo Pharma Limited has announced that the Company has received final approval from the US Food & Drug Administration...

AstraZeneca Gets SEC Nod to Update Lokelma Prescribing Information for Hyperkalemia Treatment

AstraZeneca, BioInvent ink pact to evaluate BI-1206 in combo with rituximab, Calquence

Written By Ruchika Sharma12 Feb 2024 4:30 PM IST

Sweden: BioInvent International AB, a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory...

Palamur Biosciences Faces USFDA Warning for Multiple GLP Compliance Failures

GSK gets USFDA Fast Track designation for Bepirovirsen in chronic hepatitis B

Written By Ruchika Sharma12 Feb 2024 3:30 PM IST

London: GSK plc has announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for bepirovirsen, an...

Dr. Reddys Labs Bags Health Canada Nod for Ozempic Generic, OneSource to Scale Supply

Dr Reddy's Labs gets USFDA EIR for Bachupally facility

Written By Ruchika Sharma12 Feb 2024 12:42 PM IST

Hyderabad: Pharma major Dr Reddy's Labs has announced that the Company has received the Establishment Inspection Report (EIR) from the United...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok